| Immune checkpoint inhibitors in cancer therapy Y Shiravand, F Khodadadi, SMA Kashani, SR Hosseini-Fard, S Hosseini, ... Current Oncology 29 (5), 3044-3060, 2022 | 663 | 2022 |
| Understanding the tumor microenvironment for effective immunotherapy H Sadeghi Rad, J Monkman, ME Warkiani, R Ladwa, K O'Byrne, N Rezaei, ... Medicinal research reviews 41 (3), 1474-1498, 2021 | 236 | 2021 |
| Circulating biomarkers in patients with glioblastoma J Müller Bark, A Kulasinghe, B Chua, BW Day, C Punyadeera British journal of cancer 122 (3), 295-305, 2020 | 234 | 2020 |
| Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel J Zhou, A Kulasinghe, A Bogseth, K O’Byrne, C Punyadeera, I Papautsky Microsystems & nanoengineering 5 (1), 8, 2019 | 179 | 2019 |
| Novel systemic inflammation markers to predict COVID-19 prognosis A Karimi, P Shobeiri, A Kulasinghe, N Rezaei Frontiers in immunology 12, 741061, 2021 | 144 | 2021 |
| The prognostic role of circulating tumor cells (CTCs) in lung cancer J Kapeleris, A Kulasinghe, ME Warkiani, I Vela, L Kenny, K O'Byrne, ... Frontiers in oncology 8, 311, 2018 | 122 | 2018 |
| Endothelial cells are not productively infected by SARS‐CoV‐2 L Schimmel, KY Chew, CJ Stocks, TE Yordanov, P Essebier, ... Clinical & translational immunology 10 (10), e1350, 2021 | 118 | 2021 |
| Circulating tumour cells in metastatic head and neck cancers A Kulasinghe, C Perry, L Jovanovic, C Nelson, C Punyadeera International journal of cancer 136 (11), 2515-2523, 2015 | 116 | 2015 |
| The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer A Kulasinghe, J Kapeleris, R Kimberley, SR Mattarollo, EW Thompson, ... Cancer Medicine 7 (12), 5910-5919, 2018 | 108 | 2018 |
| Enrichment of circulating head and neck tumour cells using spiral microfluidic technology A Kulasinghe, THP Tran, T Blick, K O’Byrne, EW Thompson, ME Warkiani, ... Scientific reports 7 (1), 42517, 2017 | 90 | 2017 |
| The effects of COVID-19 on the placenta during pregnancy HS Rad, J Röhl, N Stylianou, MC Allenby, SR Bazaz, ME Warkiani, ... Frontiers in immunology 12, 743022, 2021 | 87 | 2021 |
| Capture of circulating tumour cell clusters using straight microfluidic chips A Kulasinghe, J Zhou, L Kenny, I Papautsky, C Punyadeera Cancers 11 (1), 89, 2019 | 87 | 2019 |
| PD-L1 expressing circulating tumour cells in head and neck cancers A Kulasinghe, C Perry, L Kenny, ME Warkiani, C Nelson, C Punyadeera BMC Cancer 17 (333), 2017 | 73 | 2017 |
| Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic S Hanaei, A Takian, R Majdzadeh, CR Maboloc, I Grossmann, O Gomes, ... Disaster medicine and public health preparedness, 1-17, 2020 | 71 | 2020 |
| Short term ex-vivo expansion of circulating head and neck tumour cells A Kulasinghe, C Perry, ME Warkiani, T Blick, A Davies, K O'Byrne, ... Oncotarget 7 (37), 60101, 2016 | 66 | 2016 |
| The use of microfluidic technology for cancer applications and liquid biopsy A Kulasinghe, H Wu, C Punyadeera, ME Warkiani Micromachines 9 (8), 397, 2018 | 64 | 2018 |
| A collective route to head and neck cancer metastasis A Kulasinghe, H Schmidt, C Perry, B Whitfield, L Kenny, C Nelson, ... Scientific reports 8 (1), 746, 2018 | 64 | 2018 |
| Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) C O’Leary, H Gasper, KB Sahin, M Tang, A Kulasinghe, MN Adams, ... Pharmaceuticals 13 (10), 273, 2020 | 61 | 2020 |
| The development of a liquid biopsy for head and neck cancers H Schmidt, A Kulasinghe, L Kenny, C Punyadeera Oral oncology 61, 8-11, 2016 | 53 | 2016 |
| Cardiovascular disease in SARS‐CoV‐2 infection K Sato, JE Sinclair, H Sadeghirad, JF Fraser, KR Short, A Kulasinghe Clinical & Translational Immunology 10 (9), e1343, 2021 | 48 | 2021 |
Majid Ebrahimi Warkiani, CINSW FellowProfessor, University Technology Sydney (current); previous: UNSW, MIT, NTUPotvrđena adresa e-pošte na uts.edu.au
